Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Other Non Operating Income: 2010-2024

Historic Other Non Operating Income for Ani Pharmaceuticals (ANIP) over the last 15 years, with Dec 2024 value amounting to -$7.5 million.

  • Ani Pharmaceuticals' Other Non Operating Income rose 88.58% to -$853,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.4 million, marking a year-over-year increase of 16.23%. This contributed to the annual value of -$7.5 million for FY2024, which is 4596.86% down from last year.
  • Latest data reveals that Ani Pharmaceuticals reported Other Non Operating Income of -$7.5 million as of FY2024, which was down 4,596.86% from -$159,000 recorded in FY2023.
  • In the past 5 years, Ani Pharmaceuticals' Other Non Operating Income ranged from a high of $670,000 in FY2022 and a low of -$7.5 million during FY2024.
  • Over the past 3 years, Ani Pharmaceuticals' median Other Non Operating Income value was -$159,000 (recorded in 2023), while the average stood at -$2.3 million.
  • In the last 5 years, Ani Pharmaceuticals' Other Non Operating Income surged by 115.43% in 2022 and then tumbled by 4,596.86% in 2024.
  • Over the past 5 years, Ani Pharmaceuticals' Other Non Operating Income (Yearly) stood at -$494,000 in 2020, then plummeted by 779.15% to -$4.3 million in 2021, then skyrocketed by 115.43% to $670,000 in 2022, then tumbled by 123.73% to -$159,000 in 2023, then tumbled by 4,596.86% to -$7.5 million in 2024.